Clinical Trial Update: A Phase III Study to Test the Benefit of a New Kind of Anti-cancer Treatment in Patients With Melanoma, After Surgical Removal of Their Tumor [Phase 3]

View source ↗

Summary

Phase III trial in melanoma was terminated; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: GlaxoSmithKline | Conditions: Melanoma | Phase 3 | Status: TERMINATED | Results posted: 2019-03-19